SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2013 and 2014 medical device user fees for the Food and Drug Administration. Food and Drug Administration Safety Over Sequestration Act (H.R. 2725). FDA User Fee Protection Act (S. 1413).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist., HHS; Counsel, Sen. Budget Com. |
| TODD SPANGLER | House Ed & Workforce Cte; Senate HELP Cte |
Taxation/Internal Revenue Code TAX
Medical device tax: S. 232 -- Medical Device Access and Innovation Protection Act H.R. 523 -- Protect Medical Innovation Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist., HHS; Counsel, Sen. Budget Com. |
| TODD SPANGLER | House Ed & Workforce Cte; Senate HELP Cte |
Government Issues GOV
Global Investment in American Jobs Act of 2013 (H.R.2052/S.1023).
Foreign entity interest: This legislation focuses on promoting foreign direct investment in the United States and identifying barriers to such investment. Smith & Nephew, Inc.'s parent company Smith & Nephew plc is a British company with an interest in continuing to invest in the United States.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist, HHS; Counsel, Sen. Budget Com. |
| TODD SPANGLER | House Ed & Workforce Cte; Senate HELP Cte |
Health Issues HCR
Discussion of differences between laparoscopic and hysteroscopic morcellation procedures. "Sensible Oversight for Technology which Advances Regulatory Efficiency Act of 2013" (H.R. 3303). "Preventing Regulatory Overreach To Enhance Care Technology Act of 2014" (S. 2007). Custom Device Exemption: Draft Guidance for Industry and Food and Drug Administration Staff (FDA-2013-D-1601).Final Rule - Unique Device Identification System: September 24, 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist., HHS; Counsel, Sen. Budget Com. |
| TODD SPANGLER | House Ed & Workforce Cte; Senate HELP Cte |
Medicare/Medicaid MMM
CY 2015 Medicare proposed rule for hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system: Provisions related to packaging of drugs and biologicals.Comprehensive Care Payment Innovation Act (H.R. 3796). Protecting Access to Medicare Act of 2014 (H.R. 4302), in regard to ICD-10. Issues related to Medicare coverage and payment for durable medical equipment. SGR Repeal and Medicare Beneficiary Access Act (S. 1871) Medicare Drug Savings Act (H.R. 1588, S. 740) Protecting the Integrity of Medicare Act of 2014 (H.R. 5780)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Spec. Assist, HHS; Counsel, Sen. Budget Com. |
| TODD SPANGLER | House Ed & Workforce Cte; Senate HELP Cte |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.